While NAC use is limited by its poor bioavailability in brain tissue, these results may indicate that de-nitrosylating proteins of the Trx family such as (Grx, Srxn1and Prx2) may represent a new class of disease modifying targets against PD. This evidence concerns the gene PRDX2 and Parkinson disease.